New investigations are paving the way for significant possibilities in addressing MS. Emphasis is currently on disease-modifying therapies that not only halt disease worsening, but even regenerate damaged myelin. Cutting-edge approaches include new medications targeting specific immune system mechanisms and assessing the potential of cell-based tre